T. Rowe Price Associates’s AbbVie ABBV Stock Holding History

T. Rowe Price Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.68B	Buy	9,060,032 +1,865,218	+26%	+$346M	0.19%	100
2025 Q1	$1.51B	Sell	7,194,814 -2,999,412	-29%	-$628M	0.19%	101
2024 Q4	$1.81B	Sell	10,194,226 -63,736	-0.6%	-$11.3M	0.21%	89
2024 Q3	$2.03B	Sell	10,257,962 -685,246	-6%	-$135M	0.23%	78
2024 Q2	$1.88B	Buy	10,943,208 +199,018	+2%	+$34.1M	0.22%	84
2024 Q1	$1.96B	Buy	10,744,190 +1,291,201	+14%	+$235M	0.24%	85
2023 Q4	$1.46B	Sell	9,452,989 -3,361,579	-26%	-$521M	0.2%	109
2023 Q3	$1.91B	Sell	12,814,568 -350,146	-3%	-$52.2M	0.28%	70
2023 Q2	$1.77B	Sell	13,164,714 -4,411,166	-25%	-$594M	0.25%	76
2023 Q1	$2.8B	Sell	17,575,880 -2,847,220	-14%	-$454M	0.42%	48
2022 Q4	$3.3B	Sell	20,423,100 -4,098,236	-17%	-$662M	0.53%	40
2022 Q3	$3.29B	Sell	24,521,336 -6,286,462	-20%	-$844M	0.54%	38
2022 Q2	$4.72B	Sell	30,807,798 -5,924,329	-16%	-$907M	0.6%	24
2022 Q1	$5.95B	Buy	36,732,127 +4,146,214	+13%	+$672M	0.6%	24
2021 Q4	$4.41B	Buy	32,585,913 +6,377,892	+24%	+$864M	0.4%	41
2021 Q3	$2.83B	Sell	26,208,021 -2,791,314	-10%	-$301M	0.27%	82
2021 Q2	$3.27B	Sell	28,999,335 -3,212,860	-10%	-$362M	0.3%	64
2021 Q1	$3.49B	Sell	32,212,195 -296,222	-0.9%	-$32.1M	0.35%	53
2020 Q4	$3.48B	Sell	32,508,417 -231,462	-0.7%	-$24.8M	0.36%	58
2020 Q3	$2.87B	Sell	32,739,879 -9,038,901	-22%	-$792M	0.33%	55
2020 Q2	$4.1B	Sell	41,778,780 -1,149,050	-3%	-$113M	0.52%	34
2020 Q1	$3.27B	Buy	42,927,830 +14,838,316	+53%	+$1.13B	0.52%	31
2019 Q4	$2.49B	Buy	28,089,514 +8,310,959	+42%	+$736M	0.32%	64
2019 Q3	$1.5B	Buy	19,778,555 +14,602,485	+282%	+$1.11B	0.21%	114
2019 Q2	$376M	Buy	5,176,070 +2,326,510	+82%	+$169M	0.05%	329
2019 Q1	$230M	Sell	2,849,560 -1,757,951	-38%	-$142M	0.03%	429
2018 Q4	$425M	Buy	4,607,511 +281,296	+7%	+$25.9M	0.07%	261
2018 Q3	$409M	Sell	4,326,215 -848,371	-16%	-$80.2M	0.06%	310
2018 Q2	$479M	Sell	5,174,586 -889,660	-15%	-$82.4M	0.07%	260
2018 Q1	$574M	Sell	6,064,246 -910,500	-13%	-$86.2M	0.09%	226
2017 Q4	$675M	Buy	6,974,746 +303,472	+5%	+$29.3M	0.11%	203
2017 Q3	$593M	Buy	6,671,274 +939,171	+16%	+$83.5M	0.1%	214
2017 Q2	$416M	Buy	5,732,103 +216,810	+4%	+$15.7M	0.07%	282
2017 Q1	$359M	Sell	5,515,293 -790,302	-13%	-$51.5M	0.07%	295
2016 Q4	$395M	Sell	6,305,595 -268,546	-4%	-$16.8M	0.08%	278
2016 Q3	$415M	Buy	6,574,141 +125,191	+2%	+$7.9M	0.08%	258
2016 Q2	$399M	Sell	6,448,950 -1,387,886	-18%	-$85.9M	0.08%	262
2016 Q1	$448M	Sell	7,836,836 -1,069,896	-12%	-$61.1M	0.1%	239
2015 Q4	$528M	Sell	8,906,732 -5,021,216	-36%	-$297M	0.11%	200
2015 Q3	$758M	Sell	13,927,948 -10,984,477	-44%	-$598M	0.17%	144
2015 Q2	$1.67B	Buy	24,912,425 +6,345,049	+34%	+$426M	0.34%	66
2015 Q1	$1.09B	Buy	18,567,376 +2,774,585	+18%	+$162M	0.22%	115
2014 Q4	$1.03B	Sell	15,792,791 -281,604	-2%	-$18.4M	0.22%	114
2014 Q3	$928M	Buy	16,074,395 +4,166,310	+35%	+$241M	0.2%	122
2014 Q2	$672M	Buy	11,908,085 +2,886,871	+32%	+$163M	0.15%	172
2014 Q1	$464M	Sell	9,021,214 -4,930,955	-35%	-$253M	0.1%	238
2013 Q4	$737M	Sell	13,952,169 -208,813	-1%	-$11M	0.17%	153
2013 Q3	$633M	Buy	14,160,982 +2,120,810	+18%	+$94.9M	0.16%	168
2013 Q2	$498M	Buy	+12,040,172	New	+$498M	0.13%	204